Trial Outcomes & Findings for Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Lens Wearers (NCT NCT00953407)

NCT ID: NCT00953407

Last Updated: 2012-07-10

Results Overview

Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

128 participants

Primary outcome timeframe

4 weeks of wear

Results posted on

2012-07-10

Participant Flow

Two participants were enrolled but not dispensed due to failing inclusion/exclusion criteria. These participants were included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.

Participant milestones

Participant milestones
Measure
Nelfilcon A
Nelfilcon A contact lens
Narafilcon A
Narafilcon A contact lens
Etafilcon A
Etafilcon A contact lens
Omafilcon A
Omafilcon A contact lens
Hilafilcon B
Hilafilcon B contact lens
Overall Study
STARTED
26
25
26
25
24
Overall Study
COMPLETED
25
24
25
23
23
Overall Study
NOT COMPLETED
1
1
1
2
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Nelfilcon A
Nelfilcon A contact lens
Narafilcon A
Narafilcon A contact lens
Etafilcon A
Etafilcon A contact lens
Omafilcon A
Omafilcon A contact lens
Hilafilcon B
Hilafilcon B contact lens
Overall Study
Failed inclusion criteria
1
1
1
1
1
Overall Study
Lost to Follow-up
0
0
0
1
0

Baseline Characteristics

Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Lens Wearers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Nelfilcon A
n=26 Participants
Nelfilcon A spherical contact lens worn on a daily wear, daily disposable basis
Narafilcon A
n=25 Participants
Narafilcon A spherical contact lens worn on a daily wear, daily disposable basis
Etafilcon A
n=26 Participants
Etafilcon A spherical contact lens worn on a daily wear, daily disposable basis
Omafilcon A
n=25 Participants
Omafilcon A spherical contact lens worn on a daily wear, daily disposable basis
Hilafilcon B
n=24 Participants
Hilafilcon B spherical contact lens worn on a daily wear, daily disposable basis
Total
n=126 Participants
Total of all reporting groups
Age Continuous
29.5 years
STANDARD_DEVIATION 7.0 • n=93 Participants
31.5 years
STANDARD_DEVIATION 11.9 • n=4 Participants
29.9 years
STANDARD_DEVIATION 10.1 • n=27 Participants
28.3 years
STANDARD_DEVIATION 7.7 • n=483 Participants
30.5 years
STANDARD_DEVIATION 9.6 • n=36 Participants
29.9 years
STANDARD_DEVIATION 9.3 • n=10 Participants
Sex: Female, Male
Female
18 Participants
n=93 Participants
15 Participants
n=4 Participants
20 Participants
n=27 Participants
19 Participants
n=483 Participants
17 Participants
n=36 Participants
89 Participants
n=10 Participants
Sex: Female, Male
Male
8 Participants
n=93 Participants
10 Participants
n=4 Participants
6 Participants
n=27 Participants
6 Participants
n=483 Participants
7 Participants
n=36 Participants
37 Participants
n=10 Participants

PRIMARY outcome

Timeframe: 4 weeks of wear

Population: Per protocol. Analysis excluded major protocol deviations as determined by masked review.

Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.

Outcome measures

Outcome measures
Measure
Nelfilcon A
n=25 Participants
Nelfilcon A contact lens
Narafilcon A
n=24 Participants
Narafilcon A contact lens
Etafilcon A
n=24 Participants
Etafilcon A contact lens
Omafilcon A
n=23 Participants
Omafilcon A contact lens
Hilafilcon B
n=23 Participants
Hilafilcon B contact lens
Lens Awareness
16 Participants
2.3
12 Participants
2.8
11 Participants
3.1
9 Participants
2.5
13 Participants
3.1

Adverse Events

Nelfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Narafilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Etafilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Omafilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Hilafilcon B

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs

CIBA VISION

Phone: 1-800-241-7629

Results disclosure agreements

  • Principal investigator is a sponsor employee For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
  • Publication restrictions are in place

Restriction type: OTHER